99mTc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models
Аутори
Karageorgou, Maria-ArgyroRapsomanikis, Aristotelis-Nikolaos
Mirković, Marija D.
Vranješ-Đurić, Sanja
Stiliaris, Efstathios
Bouziotis, Penelope
Stamopoulos, Dimosthenis
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
The combination of two imaging modalities in a single agent has received increasing attention during the last few years, since its synergistic action guarantees both accurate and timely diagnosis. For this reason, dual-modality contrast agents (DMCAs), such as radiolabeled iron oxide (namely Fe3O4) nanoparticles, constitute a powerful tool in diagnostic applications. In this respect, here we focus on the synthesis of a potential single photon emission computed tomography/magnetic resonance imaging (SPECT/MRI) DMCA, which consists of Fe3O4 nanoparticles, surface functionalized with 2,3-dicarboxypropane-1,1-diphosphonic acid (DPD) and radiolabeled with 99mTc, [99mTc]Tc-DPD-Fe3O4. The in vitro stability results showed that this DMCA is highly stable after 24 h of incubation in phosphate buffer saline (~92.3% intact), while it is adequately stable after 24 h of incubation with human serum (~67.3% intact). Subsequently, [99mTc]Tc-DPD-Fe3O4 DMCA was evaluated in vivo in mice models through s...tandard biodistribution studies, MR imaging and gamma-camera imaging. All techniques provided consistent results, clearly evidencing noticeable liver uptake. Our work documents that [99mTc]Tc-DPD-Fe3O4 has all the necessary characteristics to be a potential DMCA.
Кључне речи:
biodistribution / dual-modality contrast agents / gamma-camera imaging / in vitro stability / magnetic resonance imaging / radiolabeling / technetium-99mИзвор:
Nanomaterials, 2022, 12, 15, 2728-
DOI: 10.3390/nano12152728
ISSN: 2079-4991
WoS: 00083994430000
Scopus: 2-s2.0-85136923889
Институција/група
VinčaTY - JOUR AU - Karageorgou, Maria-Argyro AU - Rapsomanikis, Aristotelis-Nikolaos AU - Mirković, Marija D. AU - Vranješ-Đurić, Sanja AU - Stiliaris, Efstathios AU - Bouziotis, Penelope AU - Stamopoulos, Dimosthenis PY - 2022 UR - https://vinar.vin.bg.ac.rs/handle/123456789/10405 AB - The combination of two imaging modalities in a single agent has received increasing attention during the last few years, since its synergistic action guarantees both accurate and timely diagnosis. For this reason, dual-modality contrast agents (DMCAs), such as radiolabeled iron oxide (namely Fe3O4) nanoparticles, constitute a powerful tool in diagnostic applications. In this respect, here we focus on the synthesis of a potential single photon emission computed tomography/magnetic resonance imaging (SPECT/MRI) DMCA, which consists of Fe3O4 nanoparticles, surface functionalized with 2,3-dicarboxypropane-1,1-diphosphonic acid (DPD) and radiolabeled with 99mTc, [99mTc]Tc-DPD-Fe3O4. The in vitro stability results showed that this DMCA is highly stable after 24 h of incubation in phosphate buffer saline (~92.3% intact), while it is adequately stable after 24 h of incubation with human serum (~67.3% intact). Subsequently, [99mTc]Tc-DPD-Fe3O4 DMCA was evaluated in vivo in mice models through standard biodistribution studies, MR imaging and gamma-camera imaging. All techniques provided consistent results, clearly evidencing noticeable liver uptake. Our work documents that [99mTc]Tc-DPD-Fe3O4 has all the necessary characteristics to be a potential DMCA. T2 - Nanomaterials T1 - 99mTc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models VL - 12 IS - 15 SP - 2728 DO - 10.3390/nano12152728 ER -
@article{ author = "Karageorgou, Maria-Argyro and Rapsomanikis, Aristotelis-Nikolaos and Mirković, Marija D. and Vranješ-Đurić, Sanja and Stiliaris, Efstathios and Bouziotis, Penelope and Stamopoulos, Dimosthenis", year = "2022", abstract = "The combination of two imaging modalities in a single agent has received increasing attention during the last few years, since its synergistic action guarantees both accurate and timely diagnosis. For this reason, dual-modality contrast agents (DMCAs), such as radiolabeled iron oxide (namely Fe3O4) nanoparticles, constitute a powerful tool in diagnostic applications. In this respect, here we focus on the synthesis of a potential single photon emission computed tomography/magnetic resonance imaging (SPECT/MRI) DMCA, which consists of Fe3O4 nanoparticles, surface functionalized with 2,3-dicarboxypropane-1,1-diphosphonic acid (DPD) and radiolabeled with 99mTc, [99mTc]Tc-DPD-Fe3O4. The in vitro stability results showed that this DMCA is highly stable after 24 h of incubation in phosphate buffer saline (~92.3% intact), while it is adequately stable after 24 h of incubation with human serum (~67.3% intact). Subsequently, [99mTc]Tc-DPD-Fe3O4 DMCA was evaluated in vivo in mice models through standard biodistribution studies, MR imaging and gamma-camera imaging. All techniques provided consistent results, clearly evidencing noticeable liver uptake. Our work documents that [99mTc]Tc-DPD-Fe3O4 has all the necessary characteristics to be a potential DMCA.", journal = "Nanomaterials", title = "99mTc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models", volume = "12", number = "15", pages = "2728", doi = "10.3390/nano12152728" }
Karageorgou, M., Rapsomanikis, A., Mirković, M. D., Vranješ-Đurić, S., Stiliaris, E., Bouziotis, P.,& Stamopoulos, D.. (2022). 99mTc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models. in Nanomaterials, 12(15), 2728. https://doi.org/10.3390/nano12152728
Karageorgou M, Rapsomanikis A, Mirković MD, Vranješ-Đurić S, Stiliaris E, Bouziotis P, Stamopoulos D. 99mTc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models. in Nanomaterials. 2022;12(15):2728. doi:10.3390/nano12152728 .
Karageorgou, Maria-Argyro, Rapsomanikis, Aristotelis-Nikolaos, Mirković, Marija D., Vranješ-Đurić, Sanja, Stiliaris, Efstathios, Bouziotis, Penelope, Stamopoulos, Dimosthenis, "99mTc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models" in Nanomaterials, 12, no. 15 (2022):2728, https://doi.org/10.3390/nano12152728 . .